Publications by authors named "Timothy Halling"

Claim this Profile
T
Thrombin Generation Kinetics are Predictive of Rapid Transfusion in Trauma Patients Meeting Critical Administration Threshold.
Taleen A MacArthur, Grant M Spears, Rosemary A Kozar, Jing-Fei Dong, Matthew Auton, Timothy M Halling

Shock· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary extracellular vesicle-associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.
Robin S Chirackal, Muthuvel Jayachandran, Xiangling Wang, Samuel Edeh, Zejfa Haskic, Timothy M Halling

Am J Physiol Renal Physiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study.
Myung S Park, Ailing Xue, Grant M Spears, Timothy M Halling, Michael J Ferrara

J Trauma Acute Care Surg· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion of stored red blood cells in trauma patients is not associated with increased procoagulant microparticles.
Satbir K Dhillon, Mindy L Houck, Donald H Jenkins, Jordan K Rosedahl, William S Harmsen, Timothy M Halling

J Trauma Acute Care Surg· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway.
Vijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, Utkarsh Painuly, Linda Wellik, Timothy Halling

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.
Vijay Ramakrishnan, Michael Timm, Jessica L Haug, Teresa K Kimlinger, Timothy Halling

Am J Hematol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.
Vijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, Michael Timm, Linda Wellik, Timothy Halling

Am J Hematol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis